SEC Form 3 · accession 0000899243-17-025668
Apellis Pharmaceuticals, Inc. · APLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Potentia Holdings, LLC
10% Owner
Period of report
Nov 8, 2017
Accepted (ET)
Nov 8, 2017 · 8:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492422
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 3,826,601 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Potentia Holdings, LLC ("Potentia")'s board of directors has voting and dispositive control over the shares held by Potentia. The members of the Potentia's board of directors are Cedric Francois, Alec Machiels, David Darst Jr., Stephen Gilles, Marie-Claude Bernal, Doug Onsi and A. Sinclair Dunlop. Because the board of directors acts by majority approval, none of the members of Potentia's board of directors has individual voting or investment power with respect to such shares.